Hemangiomas in children

New England Journal of Medicine

Volumn 341, Issue 3, 1999, Pages 173-181

  Drolet, Beth A ^a,c   Esterly, Nancy B ^a   Frieden, Ilona J ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Pediatric Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RECOMBINANT ALPHA INTERFERON; TRIAMCINOLONE;

ANGIOGENESIS; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; CRYOTHERAPY; HEMANGIOENDOTHELIOSARCOMA; HEMANGIOMA; HEMANGIOPERICYTOMA; HUMAN; KASABACH MERRITT SYNDROME; LASER SURGERY; PRIORITY JOURNAL; PYOGENIC GRANULOMA; REVIEW; ULCER;

ADRENAL CORTEX HORMONES; CRYOTHERAPY; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; LASERS;

EID: 0033565956     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199907153410307     Document Type: Review

References (73)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-20.
2. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1997;13:375-422.
3. Frieden IJ, Garzon M, Enjolras O. Vascular tumors and vascular malformations: does overlap occur? In: Program and abstracts of the 12th International Workshop on Vascular Anomalies, Berlin, Germany, June 27-28, 1998. abstract.
4. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezckowitz AB. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
5. Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997;19: 237-44.
6. Kishnani P, Iafolla AK, McConkie-Rosell A, Van Hove JLK, Kanter RJ, Kahler SG. Hemangioma, supraumbilical midline raphe, and coarctation of the aorta with a right aorta arch: single causal entity? Am J Med Genet 1995;59:448.
7. Opitz JM, Gilbert EF. CNS anomalies and the midline as a "developmental field." Am J Med Genet 1982;12:443-55.
8. Pascual-Castroviejo I, Viano J, Moreno F, et al. Hemangiomas of the head, neck and chest with associated vascular brain anomalies: a complex neurocutaneous syndrome. AJNR Am J Neuroradiol 1996;17:461-71.
9. Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of haemangiomas in infants born following chorionic villas sampling (CVS). Prenat Diagn 1995;15:209-14.
10. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983;18:894-900.
11. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331-2.
12. Vikkula M, Boon LM, Carraway KL III, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181-90.
13. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376:70-4.
14. McAllister KA, Groog KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-51.
15. Blei F, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998;134:718-22.
16. Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr 1996;128:329-35.
17. Nakayama H. Clinical and histological studies of the classification and the natural course of the strawberry mark. J Dermatol 1981;2:277-91.
18. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol 1993;10:311-33.
19. Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998;16:455-88.
20. Dubois J, Garel L, Grignon A, et al. Imaging of hemangiomas and vascular malformations in children. Acad Radiol 1998;5:390-400.
21. Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 1996;26:3-39.
22. Morelli JG, Tan OT, Yohn JJ, Weston WL. Treatment of ulcerated hemangiomas in infancy. Arch Pediatr Adolesc Med 1994;148:1104-5.
23. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 1940;59:1063-70.
24. Esterly NB. Kasabach-Merritt syndrome in infants. J Am Acad Dermatol 1983;8:504-13.
25. Shim WKT. Hemangiomas of infancy complicated by thrombocytopenia. Am J Surg 1968;116:896-906.
26. Zukerberg LR, Nikoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993;17:321-8.
27. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997;130:631-40.
28. Vin-Christian K, McCalmont T, Frieden IJ. Kaposiform hemangioendothelioma: an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol 1997;133:1573-8.
29. Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100:1377-86.
30. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996;129:346-54.
31. Cohen RC, Myers NA. Diagnosis and management of massive hepatic hemangiomas in childhood. J Pediatr Surg 1986;21:6-9.
32. Enjoins O, Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol 1997;14:173-9.
33. Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr 1997;131:643-6.
34. Burns AJ, Kaplan LC, Mulliken JB. Is there an association between hemangiomas and syndromes with dysmorphic features? Pediatrics 1991; 88:1257-67.
35. Esterly NB. Hemangiomas in infants and children: clinical observations. Pediatr Dermatol 1992;9:353-5.
36. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996;132:307-11.
37. Reese V, Frieden IJ, Paller AS, et al. Association official hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr 1993;122:379-84.
38. Hersh JH, Waterfili D, Rutledge J, et al. Sternal malformation/vascular dysplasia association. Am J Med Genet 1985;21:177-86.
39. Gorlin RJ, Kantaputra P, Aughton DJ, Mulliken JB. Marked female predilection in some syndromes associated with facial hemangioma. Am J Med Genet 1994;52:130-5.
40. Burrows PE, Robertson RL, Mulliken JB, et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998;207:601-7.
41. Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1988;83:977-80.
42. Goldberg NS, Hebert AA, Esterly NB. Sacral hemangiomas and multiple congenital anomalies. Arch Dermatol 1986;122:684-7.
43. Frieden IJ. Management of hemangiomas. Pediatr Dermatol 1997;14: 757-83.
44. Idem. Which hemangiomas to treat - and how? Arch Dermatol 1997; 133:1693-5.
45. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB, Guidelines outcomes Committee. Guidelines of care for hemangiomas of infancy. J Am Acad Dermatol 1997;37:631-7.
46. Tanner JL, Dechert MP, Frieden IJ. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics 1998;101:446-52.
47. Enjoiras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85:491-8.
48. Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisonc. J Pediatr 1996;128:141-6.
49. Gangopadhyay AN, Sinha CK, Gopal SC, Gupta DK, Sahoo SP, Ahmad M. Role of steroid in childhood haemangioma: a ten years review. Int Surg 1997;82:49-51.
50. Ozsoylu S. High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome. J Pediatr 1991;19:676.
51. Idem. Megadose methylprednisolone for diffuse infantile haemangiomatosis. Eur J Pediatr 1992;15:389.
52. Elsas FJ, Lewis AR. Topical treatment of periocular capillary hemangioma. J Pediatr Ophthalmol Strabismus 1994;31:153-6.
53. Assaf A, Nasr A, Johnson T. Corticosteroids in the management of adnexal hemangiomas in infancy and childhood. Ann Ophthalmol 1992;24: 12-8.
54. Reyes BA, Vazquez-Botet M, Capo H. Intralesional steroids in cutaneous hemangioma. J Dermatol Surg Oncol 1989;15:828-32.
55. Ruttum MS, Abrams GW, Harris GJ, et al. Bilateral retinal embolization associated with intralesional steroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 1993;30:4-7.
56. Sutula FC, Glover AT. Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma. Ophthalmic Surg 1987;18:103-5.
57. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326: 1456-63.
58. Ricketts RR, Hatley RM, Corden BJ, Sabio H, Howell CG. Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg 1994;219:605-12.
59. Tamayo L, Ortiz DM, Orozco-Covarrubias L, et al. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas. Arch Dermatol 1997;133:1567-71.
60. Soumekh B, Adams GL, Shapiro RS. Treatment of head and neck hemangiomas with recombinant interferon alpha-2B. Ann Otol Rhinol Laryngol 1994;105:201-6.
61. Barlow CF, Priebe C, Mulliken JB, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-30.
62. Greinwald JH Jr, Burke DK, Bonthius DJ, Bauman NM, Smith RJ. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999;125:21-7.
63. Garden JM, Bakus AD, Paller AS. Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis. J Pediatr 1992;120:555-60.
64. Ashinoff R, Geronemus RG. Failure of the flashlamp-pumped pulsed dye laser to prevent progression to deep hemangioma. Pediatr Dermatol 1993;10:77-80.
65. Apfelberg DB. Intralesional laser photocoagulation-steroids as an adjunct to surgery for massive hemangiomas and vascular malformations. Ann Plast Surg 1995;35:144-9.
66. Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg 1997;99:1301-8.
67. Achauer BM, Celikoz B, VanderKam VM. Intralesional bare fiber laser treatment of hemangioma of infancy. Plast Reconstr Surg 1998;101:1212-7.
68. Sherrington CA, Sim DKY, Freezer NJ, Robertson CF. Subglottic haemangioma. Arch Dis Child 1997;76:458-9.
69. Sie KC, McGill T, Healy GB. Subglottic hemangioma: ten years' experience with the carbon dioxide laser. Ann Otol Rhinol Laryngol 1994; 103:167-72.
70. Cremer HJ, Djawari D, Frühtherapie der kutanen Hämangiome mit der Kontaktkryochirugie. Chir Prax 1995;49:295-312.
71. Sarihan H, Mocan H, Yilidiz K, Abes M, Akyazici R. A new treatment with bleomycin for complicated hemangioma in children. Eur J Pediatr Surg 1997;7:158-62.
72. Pitanguy I, Machado BH, Radwanski HN, Amorim NF. Surgical treatment of hemangiomas of the nose. Ann Plast Surg 1996;36:586-92.
73. Deans RM, Harris GJ, Kivilin JD. Surgical dissection of capillary hemangiomas: an alternative to intralesional corticosteroids. Arch Ophthalmol 1992;110:1743-7